Markers of cholesterol synthesis are elevated in adolescents and young adults with type 2 diabetes
- 15 September 2020
- journal article
- research article
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 21 (7) , 1126-1131
Abstract
Background Changes in cholesterol absorption and cholesterol synthesis may promote dyslipidemia and cardiovascular disease in individuals with type 2 diabetes mellitus (T2DM). Objective To assess cholesterol synthesis and absorption in lean individuals, obese individuals, and individuals with T2DM. Methods We measured lathosterol and lanosterol (markers of cholesterol synthesis) as well as campesterol and β‐sitosterol (markers of cholesterol absorption) in the serum of 15‐26 years old individuals with T2DM (n = 95), as well as their lean (n = 98) and obese (n = 92) controls. Results Individuals with T2DM showed a 51% increase in lathosterol and a 65% increase in lanosterol compared to lean controls. Similarly, obese individuals showed a 31% increase in lathosterol compared to lean controls. Lathosterol and lanosterol were positively correlated with body mass index, fasting insulin and glucose, serum triglycerides, and C‐reactive protein, and negatively correlated with HDL‐cholesterol. In contrast, campesterol and β‐sitosterol were not altered in individuals with T2DM. Moreover, campesterol and β‐sitosterol were negatively correlated with body mass index, fasting insulin, and C‐reactive protein and were positively correlated with HDL‐cholesterol. Conclusions Adolescents and young adults with T2DM show evidence of increased cholesterol synthesis compared to non‐diabetic lean controls. These findings suggest that T2DM may promote cardiovascular disease by increasing cholesterol synthesis, and provide additional rationale for the use of cholesterol synthesis inhibitors in this group.Keywords
Funding Information
- ADA Foundation (9‐18‐CVD1‐003)
- Broad Institute (SPARC grant)
- Foundation for the National Institutes of Health (DK007260)
- National Center for Research Resources (RR025780)
- National Heart, Lung, and Blood Institute (R01‐HL‐076269, R01‐HL‐109650)
- National Institute of Diabetes and Digestive and Kidney Diseases (5K12‐DK‐094721‐04, DK075360, DK116074)
This publication has 43 references indexed in Scilit:
- Non-Cholesterol Sterol Levels Predict Hyperglycemia and Conversion to Type 2 Diabetes in Finnish MenPLOS ONE, 2013
- Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatmentDiabetology & Metabolic Syndrome, 2010
- Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM StudyJournal of Lipid Research, 2010
- Youth With Obesity and Obesity-Related Type 2 Diabetes Mellitus Demonstrate Abnormalities in Carotid Structure and FunctionCirculation, 2009
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetesAtherosclerosis, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- Overweight and hyperinsulinemia provide individual contributions to compromises in brachial artery distensibility in healthy adolescents and young adultsJournal of the American Society of Hypertension, 2007
- Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetesEuropean Journal of Clinical Nutrition, 2006
- Effect of atorvastatin on non-cholesterol sterols in patients with type 2 diabetes mellitus and cardiovascular diseasePharmacological Research, 2005